Literature DB >> 4477004

The calcium-induced dissociation of human plasma clotting factor XIII.

R D Cooke, J J Holbrook.   

Abstract

1. Large quantities of human Factor XIII were prepared from ethanol precipitates of outdated human plasma. 2. Material homogeneous after chromatography on DEAE-cellulose was further resolved into two proteins, A and B, after filtration on Sepharose 6B. 3. Protein A has a molecular weight of 350000 and a subunit structure a(2)b(2) and is activated by thrombin and calcium. Protein B is inactive and probably has a subunit structure b(2). 4. Calcium causes protein A, after thrombin cleavage, to fragment to give protein B and a protein, containing only a' subunits, which is catalytically active. The latter protein slowly forms a misty precipitate which is still active and not cross-linked covalently. This confirms the suggestion of Schwartz et al. (1971) that catalytic activity is only associated with a' subunits. 5. Iodoacetate, which inhibits the enzyme, does not inhibit dissociation and aggregation of protein A. 6. The existence of two proteins and the fragmentation are possible explanations for the wide range of molecular weights given for Factor XIII in the literature.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4477004      PMCID: PMC1168051          DOI: 10.1042/bj1410079

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

2.  [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].

Authors:  H Bohn; W Becker; H Trobisch
Journal:  Blut       Date:  1973-05

3.  [Isolation and characterization of the fibrin stabilizing factor from human thrombocytes].

Authors:  H Bohn
Journal:  Thromb Diath Haemorrh       Date:  1970-06-30

4.  Self-induced crosslinking of factor XIII.

Authors:  T Takagi; R F Doolittle
Journal:  Biochem Biophys Res Commun       Date:  1973-03-05       Impact factor: 3.575

5.  Platelet and plasma Factor 13 (fibrin-stabilizing factor).

Authors:  T H Kiesselbach; R H Wagner
Journal:  Thromb Diath Haemorrh Suppl       Date:  1967

6.  The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

7.  The transpeptidase system which crosslinks fibrin by gamma-glutamyle-episilon-lysine bonds.

Authors:  L Lorand; J Downey; T Gotoh; A Jacobsen; S Tokura
Journal:  Biochem Biophys Res Commun       Date:  1968-04-19       Impact factor: 3.575

8.  Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas.

Authors:  H Bohn
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

9.  Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme.

Authors:  S I Chung; J E Folk
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

10.  Immunological studies of coagulation factor XIII.

Authors:  E D Israels; F Paraskevas; L G Israels
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more
  7 in total

1.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

2.  Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.

Authors:  R D Cooke
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

3.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.

Authors:  S Lopaciuk; K Bykowska; J M McDonagh; R P McDonagh; W J Yount; C R Fuller; L Cooperstein; A Gray; L Lorand
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

5.  Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa.

Authors:  J M Freyssinet; B A Lewis; J J Holbrook; J D Shore
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

6.  An equilibrium study of metal ion binding to human plasma coagulation factor XIII.

Authors:  B A Lewis; J M Freyssinet; J J Holbrook
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

7.  Calcium and thiol reactivity of human plasma clotting factor XIII.

Authors:  R D Cooke; T C Pestell; J J Holbrook
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.